A pair of European biotechs hit below their mark as close of 2021 biotech IPO market chugs a little bit slower
Say hello to yet two more biotechs that jumped on a 2021 IPO this week.
German firm Evotec SE debuted a downsized IPO in the US yesterday — pricing at $21.75 per ADS share and $43.50 for a share on Nasdaq under the ticker $EVO.
The biotech announced last week that it planned to raise more than half a billion dollars by offering 22 million shares at $26.16 each — representing 11 million shares, according to an amended F-1 filed with the SEC.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
